{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:32:19Z","timestamp":1791311539379,"version":"4.3.1"},"reference-count":39,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2009,6,20]]},"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p> A recent report suggested improvements in survival after follicular lymphoma (FL), but not for all racial\/ethnic groups. To better understand the reasons for these FL survival differences, we examined the joint influences of diagnostic period, race\/ethnicity, and neighborhood socioeconomic status (SES) on survival in a large population-based case series. <\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p> All patients (n = 15,937) diagnosed with FL between 1988 and 2005 in California were observed for vital status through November 2007. Overall and FL-specific survival were analyzed with Kaplan-Meier and Cox proportional hazards regression. Neighborhood SES was assigned from United States Census data using residence at diagnosis. <\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p> Overall and FL-specific survival improved 22% and 37%, respectively, from 1988 to 1997 to 1998 to 2005, and were observed in all racial\/ethnic groups. Asian\/Pacific Islanders had better survival than non-Hispanic white, Hispanic, and black patients who had similar outcomes. Lower neighborhood SES was associated with worse survival in patients across all stages of disease (P for trend &lt; .01). Patients with the lowest SES quintile had a 49% increased risk of death from all causes (hazard ratio [HR] = 1.49, 95% CI, 1.30 to 1.72) and 31% increased risk of death from FL (HR = 1.31; 95% CI, 1.06 to 1.60) than patients with the highest SES. <\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p> Evolving therapies have likely led to improvements in survival after FL. Although improvements have occurred within all racial\/ethnic groups, lower neighborhood SES was significantly associated with substantially poorer survival. <\/jats:p><\/jats:sec>","DOI":"10.1200\/jco.2008.18.8052","type":"journal-article","created":{"date-parts":[[2009,5,19]],"date-time":"2009-05-19T01:47:03Z","timestamp":1242697623000},"page":"3044-3051","source":"Crossref","is-referenced-by-count":35,"title":["Improvements in Survival After Follicular Lymphoma by Race\/Ethnicity and Socioeconomic Status: A Population-Based Study"],"prefix":"10.1200","volume":"27","author":[{"given":"Theresa H.M.","family":"Keegan","sequence":"first","affiliation":[{"name":"From the Northern California Cancer Center, Fremont, CA; and University of Alabama at Birmingham, Birmingham, AL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"McClure","sequence":"additional","affiliation":[{"name":"From the Northern California Cancer Center, Fremont, CA; and University of Alabama at Birmingham, Birmingham, AL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Foran","sequence":"additional","affiliation":[{"name":"From the Northern California Cancer Center, Fremont, CA; and University of Alabama at Birmingham, Birmingham, AL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina A.","family":"Clarke","sequence":"additional","affiliation":[{"name":"From the Northern California Cancer Center, Fremont, CA; and University of Alabama at Birmingham, Birmingham, AL."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.11.3909"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/11.suppl_1.S23"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.1674"},{"key":"B6","first-page":"75","volume":"20","author":"Horning SJ","year":"1993","journal-title":"Semin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2005.07.006"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.3696"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22649"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.503"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04274.x"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.4618"},{"key":"B15","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1182\/blood-2005-01-0016","volume":"106","author":"Hiddemann W","year":"2005","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10894"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.8.1500"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.7.2244"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdj007"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-051672"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011240019516"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-04-0567"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.6310"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200408150-00012"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3322\/CA.2007.0011"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00792.x"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1532\/IJH97.NA0504"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05756.x"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi076"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.9.2431"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1188\/05.ONF.250-256"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.14.1765"},{"key":"B33","first-page":"1","volume":"52","author":"Ahluwalia IB","year":"2003","journal-title":"MMWR Surveill Summ"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.82.5.703"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2307\/2676387"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1136\/jech.55.2.111"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3109\/07357900009012172"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2007.125"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1080\/1042819021000038010"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-03-0250"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-05-0549"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4434"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2008.07.015"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2008.18.8052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T23:25:20Z","timestamp":1653521120000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2008.18.8052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,20]]},"references-count":39,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2009,6,20]]}},"alternative-id":["10.1200\/JCO.2008.18.8052"],"URL":"https:\/\/doi.org\/10.1200\/jco.2008.18.8052","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,20]]}}}